Published September, 2018
The Effect of Female Sex on Hepatitis C Incidence Among People Who Inject Drugs: Results from the International Multicohort InC3 Collaborative Aryan Esmaeili et al, Clinical Infectious Diseases (2018)
Women who inject drugs are at greater risk of acquiring hepatitis C (HCV) infection, independent of other factors such as risk behaviors or demo- graphic characteristics. Researchers reviewed data from the InC3 Collaborative which combines data from 10 different studies that collect information on incident cases of HIV and hepatitis C (HCV) among people who inject drugs (PWID). Their analysis shows that, compared to men, women who inject drugs have a 38% higher risk of incident HCV not explained by individual injection risk behaviors such as receptive syringe sharing. The authors hypothesize that multiple factors may contribute to this disparity, including biological (hormonal) characteristics, social net- works, and differences in access to prevention services. The article con- cludes by pointing to the need for further research on the various factors that may make women more susceptible to HCV, which will enable the design of interventions to more effectively reduce HCV acquisition in women.
Copyright Information: CHLP encourages the broad use and sharing of resources. Please credit CHLP when using these materials or their content. and do not alter, adapt or present as your work without prior permission from CHLP.
Legal Disclaimer: CHLP makes an effort to ensure legal information is correct and current, but the law is regularly changing, and the accuracy of the information provided cannot be guaranteed. The legal information in a given resource may not be applicable to all situations and is not—and should not be relied upon—as a substitute for legal advice.